Health News
Students Saving Their Hides From Indoor Tanning
That "healthy glow" you get from indoor tanning might not be so healthy — especially for people who start tanning at a young age. Fortunately, teens are less likely to tan now than they were a few years ago.
FDA Approves New Skin Cancer Rx
Bristol-Myers Squibb's new skin cancer drug has been approved by the US Food and Drug Administration (FDA).
Singer Joe Cocker Dies at 70
British-born blues and rock singer Joe Cocker has died at the age of 70 after battling lung cancer.
Bone Booster May Cut Cancer Risk
Women taking a bone-boosting medication might see a surprising result — a lower risk of a type of cancer.
FDA Approves Lynparza to Treat Advanced Ovarian Cancer
The U.S. Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.
7 Ways to Boost Your Immune System
Flu season is upon us! Check out these tips to boost your immune system - before you get the sniffles!
Live Long and Prosper: Global Wellness Increased
Good news for the people of Earth: people are living much longer than they were 20 years ago, and death rates have dropped for certain cancers, heart disease, stroke and other major diseases around the world.
Up in the Air, Radiation Exposure Was Higher
Pilots and cabin crew members may want to make sure sunscreen is part of their pre-flight routine.
New Treatment Helped More Patients Ditch Nicotine
If you can fight fire with fire, why not fight addiction to nicotine with another chemical?
FDA Approved Somatuline Depot Injection for Pancreatic and Gastrointestinal Neuroendorcine Tumors
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Somatuline® Depot® (lanreotide) Injection 120 mg (referred to as Somatuline®) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).